Stay updated with breaking news from Sk Bioscience Co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SK Bioscience Co. Ltd. and Vaxxas Pty. Ltd. have entered into a joint development agreement that could revolutionize vaccines by developing a vaccine-delivery device combination product using Vaxxas’ high-density microarray patch (HD-MAP) coupled with SK Bioscience’s typhoid vaccine, Skytyphoid.
Novavax reported a second-quarter profit on Tuesday, helped by strong revenue from its COVID-19 vaccines, but still trimmed its full-year forecast for sales…
By Kwanwoo Jun SK Bioscience Co Ltd.'s shares rallied Thursday after the global phase 3 clinical trials confirmed the efficacy and safety of its Covid-19 vaccine booster. Shares of the... | April 13, 2023
(Oct 26): Lotte Group, a South Korean conglomerate that sells everything from gum to hotel rooms, is doubling down on drug manufacturing in the US and eyeing opportunities in Europe and at home after the launch of its pharmaceutical arm.
Korea's new COVID-19 cases fell below 60,000 on Friday, continuing the modest decline as the omicron spread has been slowing. ...